UVA is stepping up its efforts to implement strategies for early diagnosis and is setting the standard for surgical outcomes nationwide.
Tag: uva cancer center (Page 7)
Precision Breast IORT is a unique form of IORT developed at UVA — now being examined in a Phase II clinical trial — that incorporates CT imaging and high-dose rate (HDR) brachytherapy.
UVA earns accreditation for its use of stem cells and bone marrow to treat patients with blood cancers, including leukemia, lymphoma and multiple myeloma
Out of almost 100,000 nominations, hospital leaders and cancer specialists developed the list of top cancer doctors.
UVA Cancer Center has been awarded a three-year accreditation in radiation oncology by the American College of Radiology (ACR).
Robert Dreicer, MD, MS, FACP, FASCO, is the center’s new deputy director, associate director for clinical research and head of the section of medical oncology within the Division of Hematology/Oncology.
UVA Cancer Center is growing its Stem Cell Transplant Program and pioneering new approaches to treat AML and other hematological malignancies.
UVA is recruiting highly skilled clinicians and active research scientists who are dedicated to discovering and utilizing enhanced diagnostic tools and advanced treatments for thoracic malignancies.
With a recent $10 million NIH program project grant, UVA top minds are working to reveal the potential of nanotechnology to treat cancer. Get a breakdown of how these tiny particles enhance drug delivery and learn how UVA is putting them to use.
UVA is among the "100 Hospitals and Health Systems with Great Oncology Programs" according to Becker’s Hospital Review.